Novavax Other Liab vs Cash Analysis
| 0A3S Stock | 11.90 3.06 34.62% |
Novavax financial indicator trend analysis is infinitely more than just investigating Novavax recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novavax is a good investment. Please check the relationship between Novavax Other Liab and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.
Other Liab vs Cash
Other Liab vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novavax Other Liab account and Cash. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Novavax's Other Liab and Cash is -0.7. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Cash in the same time period over historical financial statements of Novavax, assuming nothing else is changed. The correlation between historical values of Novavax's Other Liab and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Novavax are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Other Liab i.e., Novavax's Other Liab and Cash go up and down completely randomly.
Correlation Coefficient | -0.7 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Other Liab
Cash
Cash refers to the most liquid asset of Novavax, which is listed under current asset account on Novavax balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Novavax customers. The amounts must be unrestricted with restricted cash listed in a different Novavax account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Novavax's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novavax current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.Selling General Administrative is likely to gain to about 175.4 M in 2024
Novavax fundamental ratios Correlations
Click cells to compare fundamentals
Novavax Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Novavax fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Current Liab | 1.7M | 278.3M | 1.4B | 1.3B | 1.5B | 1.5B | |
| Total Current Liabilities | 25.8M | 579.7M | 2.4B | 2.5B | 2.8B | 3.0B | |
| Other Liab | 12.6M | 3.4M | 175.5M | 185.0M | 212.8M | 223.4M | |
| Net Tangible Assets | (242.8M) | 486.1M | (483.2M) | (760.4M) | (684.4M) | (650.1M) | |
| Retained Earnings | (1.4B) | (1.9B) | (3.6B) | (4.3B) | (3.8B) | (3.7B) | |
| Accounts Payable | 2.9M | 54.3M | 127.1M | 216.5M | 249.0M | 261.4M | |
| Other Assets | 7.5M | 5.4M | 24.3M | 28.5M | 32.7M | 34.4M | |
| Other Current Assets | 7.3M | 103.5M | 56.1M | 86.7M | 99.7M | 58.3M | |
| Other Stockholder Equity | (12.5M) | 7.0M | (1.4M) | (6.4M) | (7.3M) | (7.7M) | |
| Total Current Assets | 97.2M | 1.2B | 2.2B | 1.7B | 2.0B | 1.0B | |
| Common Stock | 324K | 714K | 764K | 868K | 781.2K | 813.2K | |
| Property Plant Equipment | 11.4M | 187.7M | 265.9M | 400.5M | 460.6M | 483.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.